Jeffery J. Auletta, MD :: Nationwide Children's Hospital, Columbus, Ohio

Contact Information

Hematology & Oncology
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-3550
FX: (614) 722-3369

Location Information for Patients

Main Campus

Biography

Dr. Auletta is the Director of the Blood and Marrow Transplant (BMT) Program and the Host Defense and Immunocompromised Infectious Diseases (HD) Program at Nationwide Children's Hospital. He is a physician in both Hematology/Oncology/BMT and Infectious Diseases at Nationwide Children’s Hospital. Dr. Auletta is an associate professor of Pediatrics at The Ohio State University College of Medicine. He is a member of the Leukemia Research Program at The NCI-designated Ohio State University Comprehensive Cancer Center and a member of the Center for Regenerative Medicine and Cell-based Therapies at The Ohio State University. Dr. Auletta completed his internship and residency in Pediatrics and his fellowships in both Pediatric Hematology-Oncology and Pediatric Infectious Diseases at University Hospitals and Case Medical Center/Rainbow Babies & Children’s Hospital. He earned his doctor of medicine from Case Western Reserve University School of Medicine and his bachelor of arts from Northwestern University. Dr. Auletta is a member of several professional organizations, including the Children’s Oncology Group (COG), the American Society for Blood and Marrow Transplantation (ASBMT), the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA). He is Co-Chair for the Infection and Immune Reconstitution Working Committee of the Center for International Blood & Marrow Transplant Research (CIBMTR) and for the Supportive Care Committee of the Pediatric Blood and Marrow Transplant Consortium (PBMTC).

Gender:

  • Male

Languages Spoken:

  • English

Education and Training

Medical School

  • Case Western Reserve University
    Date Completed: 06/30/1996

Residency

  • University Hospitals Case Medical Center
    Date Completed: 06/30/1999

Fellowship

  • University Hospitals Case Medical Center
    Date Completed: 06/30/2003

Fellowship

  • University Hospitals of Cleveland
    Date Completed: 06/30/2003

Department:

  • Pediatrics

Section:

  • Hematology & Oncology

Specialty:

  • Pediatric Hematology Oncology
  • Pediatric Infectious Diseases
  • Pediatrics

Date of Appointment at Nationwide Children’s Hospital:

  • 12/03/2012

Publications

  • Maziarz RT, Brazauskas B, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Leee JW, Liesveld JL, Ramanathan M, Redy V, Savani BN, Smith FO, Strasfeld L, Taplitz Ra, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML. 2016. Pre-Existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.  BONE MARROW TRANSPLANTATION. Vol. 52, no. 2. (December): 270-278.
  • Ballen,Karen; Ahn,Kwang,Woo; Chen,Min; Abdel-Azim,Hisham; Ahmed,Ibrahim; Aljurf,Mahmoud; Antin,Joseph; Bhatt,Ami,S; Boeckh,Michael; Chen,George; Dandoy,Christopher; George,Biju; Laughlin,Mary,J; Lazarus,Hillard,M; MacMillan,Margaret,L; Margolis,David,A; Marks,David,I; Norkin,Maxim; Rosenthal,Joseph; Saad,Ayman; Savani,Bipin; Schouten,Harry,C; Storek,Jan; Szabolcs,Paul; Ustun,Celalettin; Verneris,Michael,R; Waller,Edmund,K; Weisdorf,Daniel,J; Williams,Kirsten,M; Wingard,John,R; Wirk,Baldeep; Wolfs,Tom; Young,Jo-Anne,H; Auletta,Jeffrey; Komanduri,Krishna,V; Lindemans,Caroline; Riches,Marcie,L. 2016. Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 22, no. 9. (September): 1636-1645.
  • Ramanathan,M; Teira,P; Battiwalla,M; Barrett,J; Ahn,K,W; Chen,M; Green,J; Laughlin,M; Lazarus,H,M; Marks,D; Saad,A; Seftel,M; Saber,W; Savani,B; Waller,E,K; Wingard,J; Auletta,J,J; Lindemans,C,A; Boeckh,M; Riches,M,L. 2016. Impact of early CMV reactivation in cord blood stem cell recipients in the current era.  BONE MARROW TRANSPLANTATION. Vol. 51, no. 8. (August): 1113-1120.
  • Thompson,Joel; Auletta,Jeffery; Muszynski,Jennifer; Hall,Mark. 2016. IMMUNE FUNCTION AND MINIMAL RESIDUAL DISEASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA. In American Society of Pediatric Hematology/Oncology (ASPHO) 29th Annual Meeting
  • Rangarajan,Hemalatha,G; Abusin,Ghada,A; Bajwa,Rajinder; Auletta,Jeffery,J; Horwitz,Edwin,M; Abu-Arja,Rolla. 2016. SEVERE TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (TA-TMA) IN PATIENTS WITH HEMOGLOBINOPATHIES: A CASE SERIES. In American Society of Pediatric Hematology/Oncology (ASPHO) 29th Annual Meeting, Minneapolis, MN (May 2016)
  • Overholt,Kathleen; Rangarajan,Hemalatha; Joshi,Sarita; Rose,Melissa; Bajwa,Rajinder; Abu-Arja,Rolla; Auletta,Jeffery; Horwitz,Edwin. 2016. HEMATOPOIETIC CELL TRANSPLANTATION FOR CHILDREN WITH OSTM1-OSTEOPETROSIS: BRIEF REPORT. In American Society of Pediatric Hematology/Oncology (ASPHO) 29th Annual Meeting, Minneapolis, MN (May 2016)
  • Teira,Pierre; Battiwalla,Minoo; Ramanathan,Muthalagu; Barrett,A,John; Ahn,Kwang,Woo; Chen,Min; Green,Jaime,S; Saad,Ayman; Antin,Joseph,H; Savani,Bipin,N; Lazarus,Hillard,M; Seftel,Matthew; Saber,Wael; Marks,David; Aljurf,Mahmoud; Norkin,Maxim; Wingard,John,R; Lindemans,Caroline,A; Boeckh,Michael; Riches,Marcie,L; Auletta,Jeffery,J. 2016. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.  BLOOD. Vol. 127, no. 20. (May): 2427-2438.
  • Williams,K,M; Ahn,K,W; Chen,M; Aljurf,M,D; Agwu,A,L; Chen,A,R; Walsh,T,J; Szabolcs,P; Boeckh,M,J; Auletta,J,J; Lindemans,C,A; Zanis-neto,J; Malvezzi,M; Lister,J; de Toledo Codina,J,S; Sackey,K; Chakrabarty,J,LH; Ljungman,P; Wingard,J,R; Seftel,M,D; Seo,S; Hale,G,A; Wirk,B; Smith,M,S; Savani,B,N; Lazarus,H,M; Marks,D,I; Ustun,C; Abdel-Azim,H; Dvorak,C,C; Szer,J; Storek,J; Yong,A; Riches,M,R. 2016. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.  BONE MARROW TRANSPLANTATION. Vol. 51, no. 4. (April): 573-580.
  • Vasu,Sumithira; Geyer,Susan; Bingman,Anissa; Auletta,Jeffery,J; Jaglowski,Samantha; Elder,Pat; Donnell,Lynn,O; Bradbury,Hillary; Kitzler,Rhonda; Andritsos,Leslie; Blum,William; Klisovic,Rebecca; Penza,Sam; Efebera,Yvonne; Hofmeister,Craig; Benson,Don,M; Muthusamy,Natarajan; Lozanski,Gerard; Devine,Steven,M. 2016. Granulocyte Colony-Stimulating Factor Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 22, no. 4. (April): 658-668.
  • Auletta,J,J; Devine,S,M; Waller,E,K. 2016. Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?.  BONE MARROW TRANSPLANTATION. Vol. 51, no. 3. (March): 333-343.
  • Copacia,Jessica,Ann; Taylor,Kimberly; Laudick,Melissa; Abu-Arja,Rolla; Auletta,Jeffery,J; Rangarajan,Hemalatha,G; Horwitz,Edwin,M; Stanek,Joesph; Pai,Vinita,B; Bajwa,Rajinder. 2016. 70% Ethanol for Decontamination of Cvl Exposed to Calcineurine Inhibitors. In BMT Tandem Meetings, Honolulu, HI (February 2016)
  • Hayes,Don; Auletta,Jeffery,J; Whitson,Bryan,A; Black,Sylvester,M; Kirkby,Stephen; Tobias,Joseph,D; Mansour,Heidi,M. 2016. Human leukocyte antigen mismatching and survival after lung transplantation in adult and pediatric patients with cystic fibrosis.  JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. Vol. 151, no. 2. (February): 549-U391.
  • Naples,J,C; Skeens,M,A; Auletta,J; Rangarajan,H; Abu-Arja,R; Horwitz,E; Stanek,J; Bajwa,R,S. 2016. Anicteric veno-occlusive disease after hematopoietic stem cell transplantation in children.  BONE MARROW TRANSPLANTATION. Vol. 51, no. 1. (January): 135-137.
  • Burke,Michael,J; Verneris,Michael,R; Le Rademacher,Jennifer; He,Wensheng; Abdel-Azim,Hisham; Abraham,Allistair,A; Auletta,Jeffery,J; Ayas,Mouhab; Brown,Valerie,I; Cairo,Mitchell,S; Chan,Ka,Wah; Diaz Perez,Miguel,A; Dvorak,Christopher,C; Egeler,R,Maarten; Eldjerou,Lamis; Frangoul,Haydar; Guilcher,Gregory,MT; Hayashi,Robert,J; Ibrahim,Ahmed; Kasow,Kimberly,A; Leung,Wing,H; Olsson,Richard,F; Pulsipher,Michael,A; Shah,Niketa; Shah,Nirali,N; Thiel,Elizabeth; Talano,Julie-An; Kitko,Carrie,L. 2015. Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 21, no. 12. (December): 2154-2159.
  • Abu-Arja,Rolla,F; Chernin,Leah,R; Abusin,Ghada; Auletta,Jeffery; Cabral,Linda; Egler,Rachel; Ochs,Hans,D; Torgerson,Troy,R; Lopez-Guisa,Jesus; Hostoffer,Robert,W; Tcheurekdjian,Haig; Cooke,Kenneth,R. 2015. Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia.  PEDIATRIC BLOOD & CANCER. Vol. 62, no. 9. (September): 1674-1676.
  • Docampo,Melissa,D; Auletta,Jeffery,J; Jenq,Robert,R. 2015. Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 21, no. 8. (August): 1360-1366.
  • Wang,Fangjing; Eid,Saada; Cooke,Kenneth; Auletta,Jeffery; Lee,Zhenghong. 2015. Delivery of human mesenchymal stem cells following experimental bone marrow transplantation. In Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging, Baltimore, MD (June 2015)
  • Auletta,Jeffery,J; Eid,Saada,K; Wuttisarnwattana,Patiwet; Silva,Ines; Metheny,Leland; Keller,Matthew,D; Guardia-Wolff,Rocio; Liu,Chen; Wang,Fangjing; Bowen,Theodore; Lee,Zhenghong; Solchaga,Luis,A; Ganguly,Sudipto; Tyler,Megan; Wilson,David,L; Cooke,Kenneth,R. 2015. Human Mesenchymal Stromal Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia Activity Following Experimental Allogeneic Bone Marrow Transplantation.  STEM CELLS. Vol. 33, no. 2. (February): 601-614.
  • Gonzalez B, Cabral L, Auletta JJ. 2015. Febrile Neutropenia. In Supportive Care in Pediatric Oncology. Edited by Feusner J, Hastings C, Agrawal AK. New York: Springer Berlin Heidelberg.
  • Wang,Fangjing; Eid,Saada; Dennis,James,E; Cooke,Kenneth,R; Auletta,Jeffery,J; Lee,Zhenghong. 2015. Route of delivery influences biodistribution of human bone marrow-derived mesenchymal stromal cells following experimental bone marrow transplantation.  JOURNAL OF STEM CELLS AND REGENERATIVE MEDICINE. Vol. 11, no. 2. (January): 34-43.
  • Ramanathan,Muthalagu; Teira,Pierre; Battiwalla,Minoo; Barrett,A,John; Lindemans,Caroline,A; Auletta,Jeffery; Ahn,Kwang,Woo; Chen,Min; Riches,Marcie,L; Boeckh,Michael. 2014. Early CMV Reactivation Still Remains a Cause of Increased Transplant Related Mortality in the Current Era: A CIBMTR Analysis. In 56th Annual Meeting and Exposition of the American-Society-of-Hematology, San Francisco, CA (December 2014)
  • Abu-Arja,R,F; Gonzalez,B,E; Jacobs,M,R; Cabral,L; EGLER,R; Auletta,J; Arnold,J; Cooke,K,R. 2014. Disseminated Bacillus Calmette-Guerin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.  TRANSPLANT INFECTIOUS DISEASE. Vol. 16, no. 5. (October): 830-837.
  • Auletta,J,J; Eid,S,K; Wuttisarnwattana,P; Keller,M,D; Silva,I; Wilson,D,L; Cooke,K,Robert. 2014. DEFINING THE BIODISTRIBUTION AND IMMUNOMODULATORY MECHANISMS OF HUMAN MESENCHYMAL STROMAL CELLS FOLLOWING ALLOGENEIC BMT. In 40th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Milan, Italy (March 2014)
  • Williams,Kirsten,M; Agwu,Allison,G; Chen,Min; Ahn,Kwang,Woo; Szabolcs,Paul; Boeckh,Michael,J; Auletta,Jeffery,J; Tomblyn,Marcie,R. 2014. Cibmtr Retrospective Analysis Reveals Incidence, Mortality, and Timing of Pneumocystis Jiroveci Pneumonia (PCP) after Hematopoietic Stem Cell Transplantation (HSCT). In BMT Tandem Meetings, Dallas, TX (February 2014)
  • Raina,Rupesh; Vogt,Beth; Cunningham,Robert; Cabral,Linda; Abusin,Ghada; Auletta,Jeffery,J; Cooke,Kenneth,R; Abu-Arja,Rolla. 2014. Role of Early Initiation of Continuous Veno-Venous Hemofiltration (CVVH) for Management of Sinusoidal Obstructive Syndrome (SOS) Following Stem Cell Transplant (SCT). In BMT Tandem Meetings, Dallas, TX (February 2014)
  • Ballen,Karen,K; Chen,Min; Ahn,Kwang,Woo; Boeckh,Michael,J; Auletta,Jeffery,J; Szabolcs,Paul; Tomblyn,Marcie,R. 2014. Comparison of Infection Rates Among Acute Leukemia Patients in Remission Receiving Alternative Donor Hematopoietic Cell Transplantation. In BMT Tandem Meetings, Dallas, TX (February 2014)
  • Petrosiute,Agne; Auletta,Jeffery,J; Lazarus,Hillard,M. 2012. Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.  IMMUNOTHERAPY. Vol. 4, no. 11. (November): 1139-1151.
  • Auletta,Jeffery,J; Bartholomew,Amelia,M; Maziarz,Richard,T; Deans,Robert,J; Miller,Robert,H; Lazarus,Hillard,M; Cohen,Jeffrey,A. 2012. The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.  IMMUNOTHERAPY. Vol. 4, no. 5. (May): 529-547.
  • Metheny,L,L; Eid,S; Keller,M; Van Devort,A; Lee,Z,H; Wilson,D; Auletta,J; Vant Hof,W; Paez,C; Cooke,K,R. 2012. HUMAN MULTIPOTENT ADULT PROGENITOR CELLS EFFECTIVELY MODULATE ALLOREACTIVITY AFTER BONE MARROW TRANSPLANTATION REDUCING GVHD WHILE PRESERVING GRAFT-VERSUS-LEUKEMIA ACTIVITY. In BMT Tandem Meeting, San Diego, CA (March 2012)
  • Auletta,Jeffery,J; Deans,Robert,J; Bartholomew,Amelia,M. 2012. Emerging roles for multipotent, bone marrow-derived stromal cells in host defense.  BLOOD. Vol. 119, no. 8. (February): 1801-1809.
  • Auletta,Jeffery,J; Eid,Saada; Keller,Matthew; Metheny,Leland; Guardia-Wolff,Rocio; Lee,Zhenghong; Solchaga,Luis,A; Cooke,Kenneth,R. 2011. Human Mesenchymal Stem Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia in Murine Allogeneic Bone Marrow Transplantation. In 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA (December 2011)
  • Karol,Seth; O'Riordan,Mary,Ann; Auletta,Jeffery; Ahuja,Sanjay. 2011. EVALUATION OF DIFFERENTIAL TIME-TO-POSITIVE (DTP) AS AN EARLY MARKER FOR CENTRAL-VENOUS CATHETER REMOVAL IN PEDIATRIC ONCOLOGY PATIENTS. In American Society of Pediatric Hematology/Oncology (ASPHO) 24th Annual Meeting (April 2011)
  • Auletta,Jeffery,J; Zale,Elizabeth,A; Welter,Jean,F; Solchaga,Luis,A. 2011. Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential.  Stem cells international. Vol. 2011, no. March: 235176-?.
  • Auletta,Jeffery,J; Zale,Elizabeth,A; Welter,Jean,F; Solchaga,Luis,A. 2011. Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential.  STEM CELLS INTERNATIONAL. Vol. Mar 3, no. January: e235176.
  • Auletta JJ. 2010. The Immune Response to Fungal Challenge. In The Immune respopnse o fungal challenge. Edited by Perfect J, Ghannoum M.. New York: Informal Healthcare.
  • Carlson,Eric,C; Sun,Yan; Auletta,Jeffery; Kao,Winston,WY; Liu,Chia-Yang; Perez,Victor,L; Pearlman,Eric. 2010. Regulation of corneal inflammation by neutrophil-dependent cleavage of keratan sulfate proteoglycans as a model for breakdown of the chemokine gradient.  JOURNAL OF LEUKOCYTE BIOLOGY. Vol. 88, no. 3. (September): 517-522.
  • Auletta,Jeffery,J; Cooke,Kenneth,R; Solchaga,Luis,A; Deans,Robert,J; van't Hof,Wouter. 2010. Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 16, no. 7. (July): 891-906.
  • Auletta JJ, Alabran J, Kim BG, Meyer C, Letterio J. 2010. The synthetic triterpenoid, CDDO-Me, modulates the proinflammatory response to in vivo lipopolysaccharide challenge.  JOURNAL OF CYTOKINE RESEARCH. Vol. 30, no. 7. (July): 497-508.
  • Lancioni,Christina; LaBeaud,A,Desiree; Esper,Frank; Abughali,Nazha; Auletta,Jeffery. 2009. Pulmonary Tuberculosis Presenting as Fever Without Source in a Pediatric Patient With Acute Lymphoblastic Leukemia.  PEDIATRIC BLOOD & CANCER. Vol. 53, no. 7. (December): 1318-1320.
  • Reineks,Edmunds,Z; Osei,Ebenezer,S; Rosenberg,Arlene; Auletta,Jeffrey; Meyerson,Howard,J. 2009. CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells.  Cytometry. Part B, Clinical cytometry. Vol. 76, no. 4. (July): 237-248.
  • Auletta,Jeffery,J; Cooke,Kenneth,R. 2009. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.  CURRENT OPINION IN PEDIATRICS. Vol. 21, no. 1. (February): 30-38.
  • Auletta,Jeffery,J; Maitra,Basabi; Szekely,Emese; Solchaga,Luis. 2006. Toll-like receptor-stimulated CD14(+) monocytes induce soluble factors that activate human mesenchymal stem cells to inhibit T-cell alloreactivity. In 48th Annual Meeting of the American-Society-of-Hematology, Tampa, FL (December 2006)
  • Gupta,Sameer; Gould,Meetha,P; DeVecchio,Jennifer; Canaday,David,H; Auletta,Jeffery,J; Heinzel,Frederick,P. 2006. CpG-Induced IFN gamma expands TLR4-specific IL-18 responses in vivo.  CELLULAR IMMUNOLOGY. Vol. 243, no. 2. (October): 75-82.
  • Greene,Jennifer,A; DeVecchio,Jennifer,L; Gould,Meetha,P; Auletta,Jeffery,J; Heinzel,Frederick,P. 2006. In vivo and in vitro regulation of type IIFN synthesis by synergistic effects of CD40 and type IIIFN.  JOURNAL OF IMMUNOLOGY. Vol. 176, no. 10. (May): 5995-6003.
  • Auletta JJ, DeVecchio JL, Xu L, Heinzel FP. 2005. Post-transplant administration of flt3 ligand enhances innate cellular-mediated immune responses to Toll-like receptor agonists in syngeneic bone marrow transplant recipient mice. In American Society of Hematology 47th Annual Meeting & Exposition, Atlanta, GA (December 2005)
  • Auletta,J,J; Maitra,B; Szekely,E; Koc,O,N. 2005. Toll-like receptor agonists induce secretion of immunomodulatory soluble factors from human mesenchymal stem cells. In 47th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA (December 2005)
  • Yadavalli,G,K; Chien,J,W; Wener,K,M; DeVecchio,J,L; Gupta,S; Salata,R,A; Lee,J,H; Caldeira,C; Auletta,J,J; Heinzel,F,P. 2005. Interleukin 12 and interferon-gamma synthetic deficiency is associated with dendritic cell cytopenia after cardiac surgery.  SHOCK. Vol. 24, no. 1. (July): 26-33.
  • Auletta,J,J; Lazarus,H,M. 2005. Immune restoration following hematopoietic stem cell transplantation: an evolving target.  BONE MARROW TRANSPLANTATION. Vol. 35, no. 9. (May): 835-857.
  • Auletta,J,J; DeVecchio,J,L; Ferrara,J,LM; Heinzel,F,P. 2004. Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation.  BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. Vol. 10, no. 12. (December): 834-847.
  • Auletta,J,J; DeVecchio,J,L; Ferrara,J,LM; Heinzel,F,P. 2002. Distinct phases in reconstituted innate immunity: Implications for host defense. In 44th Annual Meeting of the American-Society-of-Hematology
  • Auletta, J,J; John C,C. 2002. Community-acquired, non-antibiotic associated Clostridium difficile colitis in a child.  INFECTIOUS DISEASE CLINICAL PRACTICE. Vol. 11, no. 7. (July): 397-398.
  • Yadavalli,G,K; Auletta,J,J; Gould,M,P; Salata,R,A; Lee,J,H; Heinzel,F,P. 2001. Deactivation of the innate cellular immune response following endotoxic and surgical injury.  EXPERIMENTAL AND MOLECULAR PATHOLOGY. Vol. 71, no. 3. (December): 209-221.
  • Auletta,J,J; Fisher,V,L. 2001. Immune reconstitution in pediatric stem-cell transplantation.  FRONTIERS IN BIOSCIENCE-LANDMARK. Vol. 6, no. August: G23-G32.
  • Auletta,J,J; John,C,C. 2001. Spinal epidural abscesses in children: A 15-year experience and review of the literature.  CLINICAL INFECTIOUS DISEASES. Vol. 32, no. 1. (January): 9-16.
  • Auletta, J,J; Shurin, S,B. 2000. Eosinophilia: what does it mean?.  CONTEMPORARY PEDIATRICS. Vol. 17, no. 6. (June): 61-71.
  • Auletta, J,J; O'Riordan, M,A; Nieder, M,L. 1999. Atrophine-midazolam-ketamine: efficacy and safety in pediatric oncology patients.  CURRENT THERAPEUTIC RESEARCH. Vol. 60, no. 12. (December): 683-693.
  • Auletta,J,J; O'Riordan,M,A; Nieder,M,L. 1999. Infections in children with cancer: A continued need for the comprehensive physical examination.  JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. Vol. 21, no. 6. (November): 501-508.
  • Auletta,J,J; Shurin,S. 1999. Improved hematopoiesis using amifostine in secondary myelodysplasia.  JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. Vol. 21, no. 6. (November): 531-534.
  • Auletta JJ, Nieder ML. 1997. Infectious rates in children with cancer in the 1990s. In American Society of Pediatric Hematology/Oncology Convention, San Francisco, CA (September 1997)
  • Zale EA, Auletta JJ, Solchaga L. The immunosuppressive potential of mesenchymal stem cells; Effects of time in culture and growth factor supplementation. In MSC 2009, Regenerative Medicine and Adult Stem Cell Therapy, Cleveland, OH (August 2009)
  • Sullivant K, Qutaish M, Wuttisarnwattana P, Gargesha M, Katari S, Lu H, Deshmane A, Tenley N, Molter J, Eid S, Auletta J, Raber A, van’t Hof W, Cooke K, Lee Z, Wilson DL. Cryo-imaging and SPECT imaging of multipotent adult progenitor cells in a mouse model of graft-versus-host disease. In Poster Presentation, 2011 World Molecular Imaging Congress (September 2011)
  • Jaroscak J, Auletta J, Fisher V, Wiersma S, Nieder M. Aluminum toxicity from alum bladder irrigation – a toxicity case report. In Marrow Transplantation in Children: Current Results and Controversies, World Golf Village Renaissance Resort, St. Augustine, FL (November 2001)
  • Papanicolaou GA, Ustun C, Young JAH, Chen M, Kim S, Ahn KW, Auletta JJ, Lindemans CA, Komanduri KV, Riches ML. Impact of early bloodstream infection (BSI) by vancomycin-resistant enterococci (VRE) on long-term transplant outcomes. In BMT Tandem Meetings, Orlando, FL (February 2017)
  • Teira P, Battiwalla M, Ramanathan M, Barrett AJ, Ahn K, Chen M, Green J, Saad A, Antin JH, Savani BN, Lazarus HM, Seftel M, Saber W, Marks D, Aljurf M, Norkin M, Wingard JR, Lindemans CA, Boeckh M, Riches ML, Auletta JJ. 0. Early CMV reactivation increases transplant-related mortality without attenuating hematologic disease relapse risk following allogeneic hematopoietic cell transplantation: a CIBMTR study.  Blood.
  • Abu-Arja R, Chernin LR, Abusin G, Auletta J, Cabral L, Egler R, Ochs HD, Torgerson TR, Lopez-Guisa J, Hostoffer RW, Tcheurekdjian H, Cooke KR. Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia. In 5th Annual Scientific Workshop, Primary Immune Deficiency Treatment Consortium (PIDTC), Montreal, Canada (April 2015)
  • Feucht E, Auletta J, Heinzel F, Kern J, Weinberg A. Lipopolysaccharide suppression of respiratory mBD-3 following bone marrow transplantation. In 2003 American Thoracic Society Annual Meeting, Seattle, WA (May 2003)
  • Van Dervort A, Eid S, Keller MD, Askew D, Auletta J, Cooke KR. Human MAPC modulation of in vitro T-cell alloreactivity. In Case Western Reserve University School of Medicine Summer Research Program, Cleveland, OH (July 2010)
  • Rangarajan HL, Stanek J, Hoyt A, Abu-Arja R, Bajwa R, Horwitz EM, Auletta JJ, Lee DA, Kumar R. Venous thromboembolism in pediatric recipients of hematopoietic stem cell transplant: A multicenter cohort study. In BMT Tandem Meetings, Orlando, FL (February 2017)
  • Dvorak, CC, Auletta, JJ. 0. Fever and Infection in the Immunocompromised Patient.
  • Curtis CA, Christ L, Kochera M, Zhang S, Auletta JJ, Saleh A. Therapy-related MDS with t(11;16)(q23;p13.3) translocation in a child with a history of Ewing’s sarcoma. In 2012 Annual Clinical Genetics Meeting, Charlotte, NC (March 2012)
  • Auletta JJ, Ardura MI, Vasu S, Huang Y, Zhao Q, Ruppert AS, Shoben A, Elder P, Bingman A, Kitzler R, Lozanski G, Abu-Arja R, Rangarajan HG, Bajwa R, Horwitz E, O’Donnell L, Jaglowski S, Klisovic RB, Penza S, Efebera YA, Hofmeister CC, Rosko AE, Benson DM, Andritsos LA, Blum W, Devine SM. Early infection attenuates hematologic malignant disease relapse following initial allogeneic hematopoietic cell transplantation. In American Society of Hematology (ASH) 58th Annual Meeting and Exposition, San Diego, CA (December 2016)
  • Dandoy CE, Ardura MI, Papanicolaou GA, Auletta JJ. Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: New considerations for a persistent nemesis.  BONE MARROW TRANSPLANTATION.
  • Love ZB, Dennis J, Wang F, Molter J, Auletta JJ, Gerson SL, Lee Z. Multi-modality imaging of MSC transplant. In Society of Nuclear Medicine 2006 Annual Meeting, San Diego, CA (May 2006)
  • Smith LC, Stanek J, O’Brien S, Abu-Arja R, Bajwa R, Horwitz EM, Auletta JJ, Lee D, Rangarajan HG. Health care utilization costs incurred during allogeneic hematopoietic cell transplantation for acute myeloid leukemia in children and adolescent and young adults (AYA): a comparative study. In BMT Tandem Meetings, Orlando, FL (February 2017)
  • Love ZB, Dennis J, Wang F, Awdallah A, Lin Yuan, Auletta J, Gerson, S, Lee Z. Imaging Human MSC transplant on small animal models. In Research ShowCase'06, Case Western Reserve University, Cleveland, Ohio (April 2006)
  • Love Z, Dennis J, Wang F, Molter J, Lin Y, Auletta J, Weisenberger A, Majewski S, Gerson S, Lee Z. Monitoring mesenchymal stem cell transplant. In Society of Nuclear Medicine 2006 Annual Meeting, San Diego, CA (May 2006)
  • Wang F, Eid S, Solchaga L, Kuang, Corn D, Auletta J, Gerson S, Cooke K, Lee Z. Imaging MSCs applied to the mouse model of GHVD. In MSC 2009, Regenerative Medicine and Adult Stem Cell Therapy, Cleveland, OH (August 2009)
  • Belsky JA, Stanek J, Ardura MI, Auletta JJ. Clinical and laboratory parameters associated with severe RSV infection in children, adolescents and young adults with underlying malignancy. In American Society of Pediatric Hematology/Oncology (ASPHO) 30th Annual Meeting, Montreal, Quebec (April 2017)
  • Auletta JJ, Ardura MI, Vasu S, Huang Y, Zhao Q, Ruppert AS, Shoben A, Elder P, Bingman A, Kitzler R, Lozanski G, Abu-Arja R, Rangarajan HG, Bajwa R, Horwitz E, O’Donnell L, Jaglowski S, Klisovic RB, Penza S, Efebera YA, Hofmeister CC, Rosko AE, Benson DM, Andritsos LA, Blum W, Devine SM. Cytomegalovirus reactivation does not increase subsequent risk for acute graft-versus-host disease, malignant disease relapse, or infection following allogeneic hematopoietic cell transplantation. In American Society of Hematology (ASH) 58th Annual Meeting and Exposition, San Diego, CA (December 2016)
  • Ramanathan M, Teira P, Battiwalla M, Barrett J, Ahn K, Chen M, Green J, Saad A, Seftel M, Saber W, Svani B, Waller E, Wingard JR, Auletta JJ, Lindemans CA, Boeckh M, Riches ML. 0. Impact of early cytomegaloviru8s reactivation in cor blood stem cell recipents in the current era.  Bone Marrow Transplant.
  • Auker KL, Keller MD, Eid S, Askew D, Auletta J, Cooke KR. Understanding mesenchymal stromal cell-mediated suppression of T cell activation during the development of acute graft versus host disease following allogeneic bone marrow transplantation. In Case Western Reserve University School of Medicine Summer Research Program, Cleveland, OH (July 2010)
  • Auletta JJ, Solchaga LA, Eid Saada, Guardia-Wolff R, Keller M, Pierce E, Askew D, Cooke KR. Human bone marrow-derived mesenchymal stem cells modulate in vivo T-cell alloreactivity and inflammation following murine hematopoietic stem cell transplantation. In MSC 2009, Regenerative Medicine and Adult Stem Cell Therapy, Cleveland, OH (August 2009)
  • Auletta JJ, Nieder ML. Efficacy and safety of atropine-midazolam-ketamine use in patients undergoing painful procedures. In Joint Annual Meeting of the International Society of Pediatric Oncology and the American Society of Pediatric Hematology/Oncology, Montreal, Canada (September 1999)
  • Sabloff M, Wang T, Zhu X, Artz AS, Adekola K, Abraham A, Auletta JJ, Battiwalla M, Beitinjaneh A, Bredeson C, Martino Burfarull R, Cahn MAD, Freytes CO, Gale RP, Ganguly S, Hale GA, Hamilton BK, Hashmi SK, Hematti P, Hildebrandt GC, Holmberg LA, Hon S, Kekre N, Lazarus HM, Lazaryan A, Luger SM, Muffly L, Nagler A, Nishihori T, Norkin M, Olsson R, Perales MA, Rashidi A, Romee R, Saad A, Seo S, Ulrickson ML, Ustun C, Wirk BM, Woolfrey AE, Yared J, Pasquini MC, Minieshi S. Impact of higher-dose total body irradiation conditioning on outcome after an allogeneic hematopoietic cell transplant (HCT) in the modern era. In BMT Tandem Meetings, Orlando, FL (February 2017)
  • Abusin G, Abu-Arja R, Bajwa R, Horwitz E, Auletta J, Rangarajan H. Severe transplant-associated thrombotic microangiopathy (TA-TMA) in patients with hemoglobinopathies: A brief report.  PEDIATRIC BLOOD AND CANCER.
  • Wang F, Eid S, Solchaga L, Corn D, Molter J, Tenley N, Kuang Y, Salem N, Auletta J, Gerson S, Cooke K, Lee Z. Multimodal imaging of MSCs into animal models of GVHD – Route of transplantation. In MSC 2009, Regenerative Medicine and Adult Stem Cell Therapy, Cleveland, OH (August 2009)
  • Patel P, Stanek J, Ardura MI, Auletta JJ. Infection and risk for disease relapse in children and adolescents and young adults with acute myelogenous leukemia. In American Society of Pediatric Hematology/Oncology (ASPHO) 30th Annual Meeting, Montreal, Quebec (April 2017)

featured video

Transforming Care for our Sickest Kids: Meet Dr. Auletta
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000